HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Berent J Prakken Selected Research

Chaperonin 60

1/2013Recognition of self-heat shock protein 60 by T cells from patients with atopic dermatitis.
10/2012TLR9 agonist CpG enhances protective nasal HSP60 peptide vaccine efficacy in experimental autoimmune arthritis.
12/2011Bystander suppression of experimental arthritis by nasal administration of a heat shock protein peptide.
11/2011Vaccination leads to an aberrant FOXP3 T-cell response in non-remitting juvenile idiopathic arthritis.
1/2009Heat shock protein 60 reactive T cells in juvenile idiopathic arthritis: what is new?
6/2006Heat-shock protein 60 as a tool for novel therapeutic strategies that target the induction of regulatory T cells in human arthritis.
7/2005Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis.
8/2003Heat shock protein 60 and adjuvant arthritis: a model for T cell regulation in human arthritis.
7/2002Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Berent J Prakken Research Topics

Disease

22Inflammation (Inflammations)
03/2016 - 01/2002
21Juvenile Arthritis (Juvenile Idiopathic Arthritis)
03/2016 - 01/2003
12Arthritis (Polyarthritis)
01/2016 - 01/2002
7Autoimmune Diseases (Autoimmune Disease)
03/2016 - 03/2004
6Experimental Arthritis
02/2014 - 01/2002
4Rheumatoid Arthritis
03/2010 - 01/2003
2Asthma (Bronchial Asthma)
10/2013 - 03/2010
2Infections
03/2013 - 06/2010
1Communicable Diseases (Infectious Diseases)
10/2018
1Acquired Immunodeficiency Syndrome (AIDS)
01/2016
1Dermatomyositis (Dermatopolymyositis)
01/2016
1Rheumatic Diseases (Rheumatism)
03/2013
1Brain Ischemia (Cerebral Ischemia)
02/2013
1Atopic Dermatitis (Atopic Eczema)
01/2013
1Glycogen Storage Disease (Glycogenosis)
03/2012
1Cytokine Release Syndrome
01/2012
1Necrosis
11/2011
1Cardiovascular Diseases (Cardiovascular Disease)
08/2010
1Obesity
08/2010
1Type 2 Diabetes Mellitus (MODY)
08/2010
1Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2010
1Adenoviridae Infections (Adenovirus Infections)
06/2010
1Epstein-Barr Virus Infections
06/2010
1Viremia
06/2010
1Macrophage Activation Syndrome
03/2010
1Chronic Obstructive Pulmonary Disease (COPD)
03/2010
1Myocardial Ischemia (Ischemic Heart Diseases)
09/2008
1Acute Coronary Syndrome
09/2008
1Myocardial Infarction
09/2008
1Reperfusion Injury
09/2008
1Rupture
09/2008
1Tetanus
02/2007

Drug/Important Bio-Agent (IBA)

11CytokinesIBA
01/2013 - 07/2002
9EpitopesIBA
07/2014 - 07/2002
9Chaperonin 60IBA
01/2013 - 07/2002
7AntigensIBA
10/2018 - 07/2002
6Peptides (Polypeptides)IBA
10/2012 - 07/2002
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016 - 01/2003
3ChemokinesIBA
10/2013 - 01/2006
3Interleukin-10 (Interleukin 10)IBA
10/2012 - 07/2002
3Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2011 - 08/2003
2Proteoglycans (Proteoglycan)IBA
01/2016 - 02/2014
2Biomarkers (Surrogate Marker)IBA
01/2016 - 08/2009
2Interleukin-6 (Interleukin 6)IBA
12/2013 - 06/2010
2Proteins (Proteins, Gene)FDA Link
08/2010 - 08/2003
2Interleukin-18 (Interleukin 18)IBA
06/2010 - 05/2007
2Interferon-gamma (Interferon, gamma)IBA
07/2005 - 01/2003
2T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
07/2005 - 07/2002
2LigandsIBA
07/2002 - 01/2002
1RNA (Ribonucleic Acid)IBA
03/2016
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2016
1InterferonsIBA
01/2016
1ChromatinIBA
09/2015
1Methotrexate (Mexate)FDA LinkGeneric
09/2015
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
04/2014
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
04/2014
1SteroidsIBA
04/2014
1Pharmaceutical PreparationsIBA
02/2014
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
12/2013
1Protein Subunit VaccinesIBA
10/2012
1Glucose (Dextrose)FDA LinkGeneric
03/2012
1Glucose-6-PhosphateIBA
03/2012
1Freund's AdjuvantIBA
12/2011
1Phosphates (Orthophosphate)IBA
12/2011
1Interleukin-2 (IL2)IBA
11/2011
1VaccinesIBA
11/2011
1AdipokinesIBA
08/2010
1Interleukin-12 (IL 12)IBA
06/2010
1Interleukin-8 (Interleukin 8)IBA
06/2010
1SirtuinsIBA
03/2010
1Therapeutic UsesIBA
03/2010
1Histone Deacetylase InhibitorsIBA
03/2010
1PerforinIBA
03/2010
1Histone Deacetylases (Histone Deacetylase)IBA
03/2010
1Interleukin-18 ReceptorsIBA
09/2009
1Carrier Proteins (Binding Protein)IBA
02/2007
1Polysaccharides (Glycans)IBA
02/2007
1ImmunosorbentsIBA
02/2007
1Immunoglobulin G (IgG)IBA
02/2007
1EnzymesIBA
02/2007
1FibrillinsIBA
01/2006
1Aggrecans (Aggrecan)IBA
01/2006
1Interleukin-1alpha (Interleukin 1 alpha)IBA
01/2003
1Interleukin-13IBA
01/2003
1Interleukin-4 (Interleukin 4)IBA
07/2002
1Transforming Growth Factor beta (TGF-beta)IBA
07/2002
1AntibodiesIBA
07/2002
1Bacterial DNAIBA
01/2002
1Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
01/2002

Therapy/Procedure

8Therapeutics
04/2014 - 08/2003
6Immunotherapy
12/2011 - 03/2004
5Stem Cell Transplantation
01/2016 - 06/2004
3Intranasal Administration
12/2011 - 07/2002
2Hematopoietic Stem Cell Transplantation
01/2016 - 05/2012
2Cardiopulmonary Bypass (Heart-Lung Bypass)
02/2013 - 01/2012
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2016
1Transitional Care
07/2013
1Deep Hypothermia Induced Circulatory Arrest
02/2013
1Mucosal Administration
12/2011
1Immunomodulation
09/2010